Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FLUTICASONE
Locally Advanced Lung Non-Small Cell Carcinoma
University of Washington
P2
BB
(66)
FULVESTRANT
Recurrent Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.
P2
BB
(66)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Rectal Carcinoma
SWOG Cancer Research Network
P2
BB
(66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Therapy-Related Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P2
BB
(66)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Graft Versus Host Disease
Monica Bhatia
P2
BB
(66)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Borderline Resectable Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
P2
BB
(66)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
P2
BB
(66)
Inno-206
ALK-Positive Anaplastic Large Cell Lymphoma
Huiqiang Huang
P2
BB
(66)
Inno-206
Duct Cell Adenocarcinoma of the Pancreas
University Health Network, Toronto
P2
BB
(66)
Inno-206
Intraocular Lymphoma
Peking Union Medical College Hospital
P2
BB
(66)
Inno-206
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
BB
(66)
Inno-206
Myelodysplastic Syndrome
Indiana University
P2
BB
(66)
Ipilimumab
Prostate Carcinoma
University Hospital, Essen
P2
BB
(66)
Irinotecan
Accelerated Phase Chronic Myelogenous Leukemia
University of Michigan Rogel Cancer Center
P2
BB
(66)
Irinotecan
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(66)
Irinotecan
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited
P2
BB
(66)
Irinotecan
Myelodysplastic Syndrome With Excess Blasts
National Cancer Institute (NCI)
P2
BB
(66)
Irinotecan
Ovarian Carcinosarcoma
National Cancer Institute (NCI)
P2
BB
(66)
Irinotecan
Wilms Tumor
Centre Oscar Lambret
P2
BB
(66)
Itraconazole
Androgen-insensitive Prostate Cancer
Pfizer
P2
BB
(66)
Itraconazole
Castration-Resistant Prostate Carcinoma
Pfizer
P2
BB
(66)
LENVATINIB
Glioblastoma
Tel Aviv Medical Center
P2
BB
(66)
Letrozole
Hormone Receptor Positive Tumor
Relay Therapeutics, Inc.
P2
BB
(66)
MAGNESIUM METALLICUM
Cancer Survivor
Beni-Suef University
P2
BB
(66)
METHOTREXATE
Chemotherapy-Induced Toxicity
Instituto do Cancer do Estado de São Paulo
P2
BB
(66)
Showing 651 to 675 of 19,639 assets
Previous
Page 27 of 786
Next